Onward Medical N.V. (EBR:ONWD)
Belgium
· Delayed Price · Currency is EUR 2.820
-0.065 (-2.25%)
Apr 28, 2026, 5:35 PM CET
Onward Medical Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 5.41 | 1.74 | 0.53 | 2.15 | 1.4 | Upgrade
|
| Revenue Growth (YoY) | 211.33% | 226.88% | -75.23% | 53.54% | 74.88% | Upgrade
|
| Cost of Revenue | 1.04 | 0.02 | 15.35 | 14.69 | 11.98 | Upgrade
|
| Gross Profit | 4.38 | 1.72 | -14.82 | -12.54 | -10.58 | Upgrade
|
| Selling, General & Admin | 27.21 | 17.92 | 15.73 | 13.74 | 13.18 | Upgrade
|
| Research & Development | 18.05 | 18.64 | 4.91 | 5.75 | 4.78 | Upgrade
|
| Operating Expenses | 45.26 | 36.56 | 20.65 | 19.49 | 17.95 | Upgrade
|
| Operating Income | -40.89 | -34.84 | -35.46 | -32.03 | -28.53 | Upgrade
|
| Interest Expense | -2.19 | -1.98 | -1.38 | -1.52 | -5.6 | Upgrade
|
| Interest & Investment Income | 0.58 | 0.79 | 0.97 | 0.06 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 1.04 | 0.37 | -0.19 | -0.02 | -0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.11 | -0.02 | -0.03 | -0.02 | Upgrade
|
| Pretax Income | -41.48 | -35.77 | -36.07 | -33.54 | -34.25 | Upgrade
|
| Income Tax Expense | 0.31 | -0.04 | 0.11 | -0.77 | 0.07 | Upgrade
|
| Net Income | -41.79 | -35.73 | -36.18 | -32.77 | -34.31 | Upgrade
|
| Net Income to Common | -41.79 | -35.73 | -36.18 | -32.77 | -34.31 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 45 | 30 | 30 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 45 | 30 | 30 | 9 | Upgrade
|
| Shares Change (YoY) | 4.58% | 47.86% | - | 218.23% | 163.40% | Upgrade
|
| EPS (Basic) | -0.90 | -0.80 | -1.20 | -1.09 | -3.62 | Upgrade
|
| EPS (Diluted) | -0.90 | -0.80 | -1.20 | -1.09 | -3.62 | Upgrade
|
| Free Cash Flow | -39.5 | -31.91 | -32.69 | -27.07 | -19.97 | Upgrade
|
| Free Cash Flow Per Share | -0.85 | -0.71 | -1.08 | -0.90 | -2.10 | Upgrade
|
| Gross Margin | 80.81% | 98.73% | - | - | - | Upgrade
|
| Operating Margin | -755.17% | -2003.68% | -6665.98% | -1491.06% | -2039.31% | Upgrade
|
| Profit Margin | -771.83% | -2054.34% | -6800.94% | -1525.70% | -2452.75% | Upgrade
|
| Free Cash Flow Margin | -729.55% | -1835.13% | -6145.11% | -1260.29% | -1427.09% | Upgrade
|
| EBITDA | -40.38 | -34.51 | -35.23 | -31.87 | -28.38 | Upgrade
|
| D&A For EBITDA | 0.51 | 0.34 | 0.23 | 0.16 | 0.15 | Upgrade
|
| EBIT | -40.89 | -34.84 | -35.46 | -32.03 | -28.53 | Upgrade
|
| Revenue as Reported | 5.41 | 1.74 | - | 2.15 | 1.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.